Who is in your network?

Cell Therapy Media market Research Report by 2023, Forecast till 2035

Roots Analysis has done a detailed study on Cell Therapy Media, Kits, Reagents and Surfaces Market, 2023-2035, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

Key Market Insights
 Leveraging their expertise, over 450 types of kits, media, reagents and extracellular matrices have been manufactured by consumable providers for research and therapeutic purposes
 The market features the presence of more than 80 firms across the globe; majority of these stakeholders are emerging players based in North America
 A larger proportion of the kits available in the cell therapy domain comprise of different types of reagents; of these, 60% are intended for use with stem cell therapies and nearly 80% are stored in refrigerated conditions
 Media developers are offering products for a broad range of cell therapies; nearly 90% of such players are providing media in the volume range of 100 to 500 ml
 Predominantly, the cell therapy reagents are intended to be used at discovery scale of operation for a wide spectrum of functions, including cell expansion and proliferation
 The market landscape of matrices, which typically have a shelf life of 1 to 1.5 years, is well distributed in terms of type of ECM coating and type of formulation
 In pursuit of gaining a competitive edge, cell therapy consumable providers are upgrading their existing technologies and expanding their product portfolios
 Many companies have undertaken strategic initiatives, including partnerships, acquisitions and expansions, to augment their existing capabilities
 We expect industry stakeholders to continue to forge strategic alliances with niche / specialized players engaged in this domain to further augment their respective product offerings
 Over the years, stakeholders within this industry have established strong brand positions by undertaking a range of initiatives to further advance the development of raw materials for cell therapies
 Cost is a key determinant for the adoption of consumables in a cell therapy manufacturing process; the pricing strategy matrix is likely to assist players in evaluating the competitive market prices for their products
 In 2035, the commercial scale of operation is likely to account for 75% of the total demand for cell therapy surface; this is attributed to the expected surge in the anticipated approvals of multiple cell therapies
 A paradigm shift from animal-based to animal component free formulations, combined with stringent regulatory guidelines, is likely to drive the growth of the cell therapy media market at an annualized rate of 12%
 The projected future opportunity for cell therapy consumable providers is expected to be well distributed across different types of end-users and key geographical regions

Table of Contents
1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Context and Background
3.2. Introduction to Cell Therapies
3.3. Comparison of Cell Therapies with Other Biopharmaceuticals
3.4. Classification of Cell Therapy Products
3.5. Overview of Cell Therapy Development and Manufacturing
3.6. Role of Raw Materials in Cell Therapy Development and Manufacturing
3.7. Types of Cell Therapy Consumables
3.8. Key Challenges Associated with Manufacturing of Cell Therapy Consumables
3.9. Future Perspectives

4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. List of Cell Therapy Kit Providers
4.3. List of Cell Therapy Media Providers
4.4. List of Cell Therapy Reagent Providers
4.5. List of Cell Therapy Extracellular Matrix Providers

5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Key Assumptions and Parameters
5.3. Methodology
5.4. Cell Therapy Consumables Providers: Company Competitiveness Analysis
5.5. Cell Therapy Kits Providers
5.6. Cell Therapy Media Providers
5.7. Cell Therapy Reagent Providers
5.8. Cell Therapy Extracellular Matrix Providers

6. BRAND POSITIONING OF KEY INDUSTRY PLAYERS
6.1. Chapter Overview
6.2. Scope and Methodology
6.3. Brand Positioning: STEMCELL Technologies
6.4. Brand Positioning: Miltenyi Biotec
6.5. Brand Positioning: Thermo Fisher Scientific
6.6. Brand Positioning: Takara Bio
6.7. Brand Positioning: GeminiBio

7. COMPANY PROFILES
7.1. Chapter Overview
7.2. STEMCELL Technologies
7.2.1. Company Overview
7.2.2. Product Portfolio
7.2.3. Recent Developments and Future Outlook
7.3. Miltenyi Biotec
7.4. Thermo Fisher Scientific
7.5. Bio-Techne
7.6. Irvine Scientific
7.7. Lonza
7.8. Sartorius
7.9. BD Biosciences
7.10. Corning
7.11. CellGenix

8. RECENT DEVELOPMENTS AND INITIATIVES
8.1. Chapter Overview
8.2. Partnership Models
8.3. Cell Therapy Consumables: Partnerships and Collaborations
8.4. Cell Therapy Consumables: Mergers and Acquisitions
8.5. Cell Therapy Consumables: Recent Expansions

9. LIKELY PARTNER ANALYSIS FOR CELL THERAPY CONSUMABLE PROVIDERS
9.1. Chapter Overview
9.2. Scoring Criteria and Key Assumptions
9.3. Scope and Methodology
9.4. Key Potential Strategic Partners for Cell Therapy Consumable Providers

10. ROOTS ANALYSIS PRICING STRATEGY
10.1. Chapter Overview
10.2. Roots Analysis Framework

11. DEMAND ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Global Demand for Cell Therapy Consumables
11.4. Analysis by Scale of Operation
11.5. Analysis by Geography

12. MARKET FORECAST AND OPPORTUNITY ANALYSIS
12.1. Chapter Overview
12.2. Key Assumptions and Methodology
12.3. Global Cell Therapy Consumables Market, 2023-2035
12.4. Cell Therapy Consumables Market: Analysis by Type of Product
12.5. Cell Therapy Consumables Market: Analysis by Type of Cell Therapy
12.6. Cell Therapy Consumables Market: Analysis by Scale of Operation
12.7. Cell Therapy Consumables Market: Analysis by Type of End-User
12.8. Cell Therapy Consumables Market: Analysis by Geography

13. UPCOMING TRENDS AND FUTURE GROWTH OPPORTUNITIES
13.1. Chapter Overview
13.2. Emerging Trends Related to Cell Culture Media
13.3. Automation of Cell Therapy Manufacturing Processes
13.4. Single Use Systems and Technologies in Cell Therapy Manufacturing

14. CONCLUDING REMARKS

15. INTERVIEW TRANSCRIPTS

16. APPENDIX I: TABULATED DATA

17. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/cell-therapy

Learn from experts: do you know about these emerging industry trends?
Unlocking the Potential of Digital Twins in Healthcare: Benefits, Challenges and Opportunities

Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#celltherapymediamarket #celltherapymediamarketsize #celltherapymedia #celltherapysurface #cellcultureconsumables

Lab Automation market Share, Growth Analysis by 2035

The “Lab Automation Market, 2023-2035” report features an extensive study of the current market landscape and future potential of the lab automation market, over the next 12 years.

Key Inclusions
 An executive summary of the insights captured during our research, offering a high-level view on the current state of lab automation market and its likely evolution in the mid-to-long term.
 A general overview of lab automation, along with details on its historical evolution, different stages and processes. In addition, the chapter presents information on the advantages of lab automation and the challenges associated with its use. Further, it concludes with a discussion on the future perspectives in this domain.
 A detailed assessment of the overall market landscape of around 350 lab automation system manufacturers, based on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, types of lab automation system(s) (automated liquid handling systems (automated integrated workstations, pipetting systems and reagent dispensers), automated microplate systems (automated microplate workstations, microplate washers, multi-mode microplate readers and single-mode microplate readers), automated assay systems, automated nucleic acid extraction systems, robotic systems, automated storage and retrieval systems (ASRS), automated sampling systems and other lab automation equipment), stage(s) of automation (pre-analytical stage, analytical stage, post-analytical stage and total lab automation), application area(s) (drug discovery, diagnostics, genomic solutions, proteomic solutions, microbiology and other applications) and end-user(s) (pharmaceutical and biotechnology companies, research and academic institutes, hospitals and diagnostic laboratories and other end-users).
 A detailed competitiveness analysis of lab automation system manufacturers based on several relevant parameters, such as company strength (in terms of number of years since it was established), product diversity (in terms of number of lab automation system being developed by the company) and product strength (in terms of stage(s) of automation, application area(s) and end-user(s)).
 Elaborate profiles of key players (shortlisted based on a proprietary criterion) engaged in the development of lab automation systems across North America, Europe and Asia-Pacific and Rest of the World. Each profile features a brief overview of the company, details related to its financial information (if available), product portfolio, recent developments and an informed future outlook.
 A detailed analysis of partnerships inked between stakeholders engaged in this domain since 2018, based on several relevant parameters, such as year of partnership, type of partnership, type of partner, type of automation instrument(s), most active players (in terms of number of partnerships) and regional distribution of partnership activity in this domain.
 An in-depth analysis of various patents that have been filed / granted related to lab automation since 2018, taking into consideration several relevant parameters, such as patent publication year, type of patent, patent jurisdiction, CPC symbols, type of applicant, emerging focus areas and leading players (in terms of number of patents filled / granted) and leading individual assignees. It also features a detailed patent benchmarking analysis and an insightful valuation analysis, highlighting the leading patents (in terms of number of citations).
 Informed estimates of the existing market size and the future opportunity for lab automation instruments, over the next 12 years. Based on multiple parameters, such as global instrumentation market in life science industry, biopharmaceutical industry and share of automation, we have provided informed estimates on the evolution of the market for the period 2023-2035.
 A case study on the lab automation software providers, providing detailed analysis on various parameters such as year of establishment, company size (in terms of number of employees), location of headquarters, type of software (laboratory information management system, laboratory information system, electronic lab notebook, scientific data management system and other software), mode(s) of deployment (cloud-based and on-premise), end-user(s) (pharmaceutical and biotechnology companies, research and academic institutes, and hospitals and diagnostic laboratories).

The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:
 Stage of Automation
 Pre-Analytical
 Analytical
 Post-Analytical
 Total Lab Automation

 Type of Instrument
 Automated Liquid Handling Systems
 Automated Microplate Readers
 Automated Sampling Systems
 Analyzers
 Automated Storage and Retrieval Systems (ASRS)
 Other Instruments

 End-User
 Pharmaceutical and Biotechnology Companies
 Research and Diagnostic Laboratories
 Other End-Users

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Middle East and North Africa
 Latin America

Key Questions Answered
 What is lab automation?
 What is automated liquid handling system? What are examples of liquid handling systems?
 How many players are currently involved in the development of lab automation systems?
 Which are the top players in the lab automation market?
 What is the global market size of the lab automation market?
 What is the growth rate of lab automation market?
 Which region is likely to hold the largest share in the lab automation market?
 What is the market share of automated liquid handling systems?
 What are the factors driving the lab automation market?

To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/lab-automati

News article
CAR-T cell therapy market

Learn from experts: do you know about these emerging industry trends?
Cell Therapy – The Revolutionary Therapeutic Modality: All Set To Obliterate Oncological Disorders
T-cell Immunotherapies: The Future of Modern Cancer Treatments

Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com


#labautomationmarket #labautomationmarketgrowth #labautomation #laboratoryautomation #laboratoryautomationmarket

Analysis of Quantum Computing market Strategies and Forecasts to 2035

The “Quantum Computing in Drug Discovery Services Market, 2023-2035” report by Roots Analysis features an extensive study of the current landscape and the likely future potential over the next decade

Key Inclusions

 A general overview of quantum computing in drug discovery services, along with information on its types and applications across various industries. It also highlights the applications of quantum computing, specifically related to drug discovery. Further, the chapter features a discussion on the challenges, key growth drivers, and future perspectives.
 A detailed assessment of the overall market landscape of quantum computing software providers, based on several relevant parameters, including year of establishment, company size (in terms of number of employees), location of headquarters, business capabilities (platform / software, quantum as a service, drug discovery service and in-house pipeline), platform capabilities (drug discovery, drug design, supply chain management and drug development(clinical trials)), type of drug discovery service(s) offered (target discovery / identification, target validation / selection, hit generation / identification / discovery, hit to lead / hit expansion / target to lead / lead identification / select lead series and lead optimization), type of molecule(s) supported (small molecules and large molecules), compatible computational approaches (artificial intelligence and cloud computing), end user(s) (pharmaceutical companies, contract research organizations and academic / research institutes) and therapeutic area(s) (cardiovascular disorders, infectious diseases, neurological disorders , oncological disorders and others)
 A detailed competitiveness analysis of quantum computing service providers based on company strength (in terms of years of experience), portfolio strength (in terms of type of drug discovery services offered, type of molecule(s) supported, type of computational approaches and type of end-user(s)), and portfolio diversity (in terms of business capabilities).
 Elaborate profiles of quantum computing software providers. Each profile includes a brief overview of the company, financial information (if available), details on service portfolio, recent developments and an informed future outlook.
 A detailed assessment of the overall market landscape of quantum computing hardware providers, based on several parameters including year of establishment, company size (in terms of number of employees), location of headquarters, type of offering(s) (hardware as a service and hardware for purchase), data storage on cloud and compatible computational approaches (artificial intelligence and cloud computing)
 Detailed profiles of quantum computing hardware providers. Each profile includes a brief overview of the company, financial information (if available), details on service portfolio, recent developments and an informed future outlook.
 A detailed review of over 170 academic grants focused on quantum computing in drug discovery, based on several relevant parameters, such as year of grants awarded, amount awarded, support period, type of study section, administering institute center, type of grant, activity code, funding mechanism and amount granted, funding institute and support period, prominent program officers (by number of grants), location of recipient organizations, popular recipient organizations, organization type and amount granted to popular recipient.
 A detailed analysis of recent partnerships inked between stakeholders engaged in this domain, since 2017, based on several relevant parameters, such as year of partnership, type of partnership, most active players (in terms of number of partnerships), and regional distribution of partnership activity in this domain.
 A use case study highlighting the applications of quantum computing across various industries, such as chemical industry, cybersecurity, financial modeling, space sciences, oil and gas industry and weather forecasting, and its likely evolution in the foreseen future.
 A qualitative analysis, highlighting the five competitive forces prevalent in this domain, including threats for new entrants, bargaining power of buyers, bargaining power of suppliers, threats of substitute product and rivalry among existing competitors.
 A detailed analysis of the current and future market based on blue ocean strategy, covering a strategic plan / guide for emerging players in this domain to help unlock an uncontested market, featuring thirteen strategic tools that can help software providers to shift towards a blue ocean strategic market.
 One of the key objectives of the report was to estimate the current opportunity and future growth potential of quantum computing in drug discovery services market over the coming years. We have provided informed estimates on the likely evolution of the market for the period, 2023-2035. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as drug discovery services offered (target identification / validation, hit generation / lead identification and lead optimization), therapeutic area (cardiovascular disorders, CNS disorders, dermatological disorders, endocrine disorders, gastrointestinal disorders, immunological disorders, infectious diseases, musculoskeletal disorders, oncological disorders, respiratory disorders and others), and key geographical regions ((North America (US and Canada), Europe (UK, France, Germany and Rest of the Europe), Asia-Pacific (China, Japan and Rest of the Asia Pacific), Latin America and Middle East and North Africa). In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of the industry’s evolution.

By 2035, the financial opportunity within the tissue engineering-based regeneration devices has been analyzed across the following segments:

 Drug Discovery Service(s) Offered
 Target Identification / Validation
 Hit Generation / Lead Identification
 Lead Optimization

 Therapeutic Area
 Cardiovascular Disorders
 CNS Disorders
 Dermatological Disorders
 Endocrine Disorders
 Gastrointestinal Disorders
 Immunological Disorders
 Infectious Diseases
 Musculoskeletal Disorders
 Oncological Disorders
 Respiratory Disorders
 Others

 Geographical Regions
 North America
 Europe
 Asia-Pacific
 Latin America
 MENA

Key Questions Answered

 What is quantum computing and how does it work in drug discovery?
 What is the current market landscape of the quantum computing market focused on drug discovery?
 What are the key trends across grants awarded for quantum computing in drug discovery?
 What are the key trends in the partnerships and collaborations for quantum computing in drug discovery?
 What is the impact of quantum computing on the pharmaceutical industry?
 What is the market size of quantum computing in drug discovery services market?
 Who are the players in the quantum computing in drug discovery services market?

To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/quantum-comp

News article
Biopharmaceutical Filtration Market

Learn from experts: do you know about these emerging industry trends?
SARM1: A Potential Therapeutic Target For Neurodegenerative Diseases
Medical Device Coatings and Modification Technologies

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#quantumcomputingmarketgrowth #quantumcomputingmarkettrends #quantumcomputingcompanies #quantumcomputingreport #quantumcomputingsoftware

Patient Recruitment Services and Patient Retention Services market Size, Share, Trends by 2035

Patient Recruitment Services and Patient Retention Services market Size, Share, Trends by 2035

The recruitment of suitable clinical trial participants is often fraught with several challenges, including scientific and operational complexity, insufficient resources and expertise, issues related to data handling and increasingly stringent regulatory guidelines.

As a result, outsourcing has become a popular operating model in this domain, as it enables reduction in costs, optimization of timelines and launch of respective offerings, as per planned timelines. In fact, several patient recruitment firms have begun adopting and implementing modern technical strategies, such as social media platforms, mobile applications, Electronic Health Records (EHRs) and Real-World Evidence (RWE) for patient enrolment.

The USD 26.2 billion (by 2035) financial opportunity within the patient recruitment and retention services market has been analyzed across the following segments:

 Patient Recruitment Step
 Pre-screening
 Screening

 Trial Phase
 Phase I
 Phase II
 Phase III
 Phase IV

 Therapeutic Area
 Cardiovascular Disorders
 Oncological Disorders
 Infectious Diseases
 CNS Disorders
 Respiratory Disorders
 Hematological Disorders
 Dermatological Disorders
 Ophthalmic Disorders
 Others

 Key Geographical Regions
 North America
 Europe
 Asia Pacific
 Latin America
 Middle East and North Africa
 Rest of the World

The Patient Recruitment Services and Patient Retention Services Market (3rd Edition), 2022-2035 report features the following companies, which we identified to be key players in this domain:
 BBK Worldwide
 Continuum Clinical
 IQVIA
 United BioSource (UBC)
 WCG ThreeWire
 Clariness
 Fidelis Research
 Ignite Data
 Innovative Trials
 Orphan Reach
 3H Medi Solution
 Buzzreach
 Current Medical Information Center (CMIC)
 nRollmed
 Trialfacts

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Patient Outreach Methods

5. Market Landscape

6. Patient Retention and Patient Recruitment Companies Competitiveness Analysis

7. Company Profiles: Patient Recruitment and Patient Retention Services Providers in North America

8. Company Profiles: Patient Recruitment and Retention Services Providers in Europe

9. Company Profiles: Patient Recruitment and Retention Services Providers in Asia-Pacific and Rest of The World

10. Partnerships and Collaborations

11. Recent Trends in Patient Recruitment and Retention

12. Future Growth Opportunities in Patient Recruitment

13. Case Study: Regulatory Landscape of Patient Recruitment

14. Patient Recruitment in Trials Focused on Personalized Medicines and Rare Diseases

15. Analysis of Demand for Clinical Trial Participants

16. Market Sizing and Opportunity Analysis

17. Concluding Remarks

18. Executive Insights

19. Appendix 1: Tabulated Data

21. Appendix 2: List of Companies and Organizations

To view more details on this report, click on the link:
https://www.rootsanalysis.com/....reports/view_documen

News article
Biopharmaceutical Filtration Market

Learn from experts: do you know about these emerging industry trends?
mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends
Exploring How Artificial Intelligence Is Transforming Digital Pathology

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#patientrecruitmentservicesandpatientretentionservicesmarket #patientrecruitmentservicesandpatientretentionservicesmarketsize #patientrecruitment #clinicaltrialpatientrecruitment #clinicaltrialrecruitment

Latest news on Bacteriophage therapy market Research Report by 2035

Bacteriophage Therapy is an attractive approach to tackle the escalating resistance against antibiotics; over the years, this upcoming class of target specific therapeutic agents has generated significant enthusiasm within the medical science community

Roots Analysis has announced the addition of “Bacteriophage Therapeutics Market, 2022-2035” report to its list of offerings.

The report features an extensive study on the current market landscape, offering an informed opinion on the likely evolution and future opportunities associated with the bacteriophage therapeutics market.

The study underlines an in-depth analysis, highlighting the key drivers and the market trends related to this evolving segment of the pharmaceutical industry. Amongst other elements, the report includes:
 A summary of the key insights from the bacteriophage therapeutics market. It offers a high-level view on the current state of the market and its likely evolution in the mid to long term.
 A general overview of the historical evolution of bacteriophages and their biology. It also includes a detailed discussion on applications of bacteriophage therapy. The chapter concludes with a discussion on the various advantages and limitations associated with the bacterio-phage therapy.
 A detailed overview of the overall market landscape of bacteriophage therapeutics, including information on their current status of development, key therapeutic areas, type of bacterial strain, target disease indication, type of therapy, route of administration, and information on bacteriophage related technologies.
 An overview of the current status of the market with respect to the players engaged in the manufacturing of bacteriophage therapeutics, featuring information on the year of establishment, company size, location of headquarters, and leading developers.
 Elaborate profiles of the prominent players engaged in the development of bacteriophage therapeutics.
 An in-depth analysis of completed, ongoing and planned clinical studies, based on several relevant parameters, such as trial registration year, trial phase, enrolled patient population, study design, type of sponsor / collaborator, most active players, registered trials, and geographical region.
 An in-depth analysis of the various patents that have been filed / granted related to bacteriophage therapeutics. It includes information on key parameters. It also highlights the leading industry and non-industry players and individual assignees.
 An in-depth analysis of various publications for bacteriophage therapeutics, based on several relevant parameters, such as year of publication, type of article, popular keywords, most popular publishers, key journals. It also highlights benchmarking of the publications to develop more insightful opinions on the recent trends related to research and development in this area.
 A detailed study of the various grants that have been awarded to research institutes engaged in projects related to bacteriophage therapeutics, since 2017, highlighting various important parameters.
 An in-depth analysis of the investments made, including grants, venture capital financing, initial public offering, secondary offering, private placement, equity and debt funding, at various stages of development, in companies that are focused on developing bacteriophage therapeutics.
 A detailed study of the recent collaborations and partnership established in this domain since 2017, including the details of deals that were / are focused on the development of bacteriophage therapeutics.
 An analysis of the various start-ups engaged in the development of bacteriophage therapeutics, based on relevant parameters, such as pipeline strength, pipeline maturity, indication diversity, number of patents, financial support and partnership activity

The financial opportunity within the bacteriophage therapeutics market has been analyzed across the following segments:
 Type of Therapeutic Area
 Gastrointestinal Infections
 Bacterial Dysentery
 Multiple Infections
 Other Infections

 Distribution by Route of Administration
 Oral Route
 Rectal Route
 Intravesical Route
 Topical Route

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Latin America
 Middle East and North Africa

Key Companies covered in the report
 Adaptive Phage Therapeutics
 ContaFect
 Eliava BioPreparations
 Micreos
 NPO Microgen
 Phagelux
 Pherecydes Pharma

For additional details, please visit https://www.rootsanalysis.com/....reports/bacteriophag

You may also be interested in the following titles:
Bispecific Antibodies Market
Novel Cell Cytometers: Need of the Hour
Bispecific Antibodies Market
Roots Analysis Consulting - the preferred research partner for global firms


About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#bacteriophagetherapymarketgrowth #bacteriophagetherapymarkettrends #bacteriophagetherapeutics #phagetherapy #bacteriophagemarket